Dr. Sonabend Worthalter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N Saint Clair St
Ste 21-100
Chicago, IL 60611Phone+1 312-695-0990Fax+1 312-695-4430
Summary
- I am a board-certified neurosurgeon and physician-scientist with a focus on brain tumors, dedicated to translational research to improve the survival of these patients. My clinical focus is on the surgical management of tumors of the brain and skull base, including gliomas, brain metastasis, intraventricular tumors, CNS lymphoma, meningiomas, and pituitary adenomas, among other tumors. As a surgeon, I integrate techniques such as radiosurgery, fluorescent microscopy, and microsurgery, as well as awake and asleep electrophysiology brain mapping techniques to achieve effective resections while preserving brain functions. Given that many malignant brain tumors are not curable, and resection only offers a limited therapeutic benefit, I integrate the standard surgeries with experimental procedures for novel therapies that are performed in the operating room. I have been involved as investigator or principal investigator in several clinical trials for brain tumors in which I performed convection-enhanced delivery, as well as intra-tumoral and peri-tumoral brain injection of viruses and biological agents, and more recently, implantation of ultrasound devices in the skull. On the other hand, I take advantage of my access to the brain to study fundamental questions of drug brain delivery directly in patients, and tumor biology in human specimens.
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Chief Residency, Neurological Surgery, 2014 - 2015
- New York Presbyterian Hospital (Columbia Campus)Residency, Neurological Surgery, 2008 - 2015
- Universidad Nacional Autonoma de MexicoClass of 2007
Certifications & Licensure
- IL State Medical License 2017 - 2026
- NY State Medical License 2015 - 2017
- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- Recruitment Award ($1,500,000 USD) Office of the Provost for Diversity and Inclusion, Columbia University, 2015
- First Place on The New York Society for Neurosurgery Resident’s Research Night Contest New York Society of Neurosurgery, 2013
- Neurosurgery Research and Education Fellowship Award American Association of Neurological Surgeons, 2012
- Join now to see all
Clinical Trials
- Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma Start of enrollment: 2020 Oct 29
Publications & Presentations
PubMed
- 192 citationsMRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastomaBrian J A Gill, David J. Pisapia, Hani Malone, Hannah E. Goldstein, Liang Lei
Proceedings of the National Academy of Sciences of the United States of America. 2014-08-26 - 64 citationsPatient-Specific Metrics of Invasiveness Reveal Significant Prognostic Benefit of Resection in a Predictable Subset of GliomasAnne Baldock, Sunyoung Ahn, Russell C. Rockne, Sandra K. Johnston, Maxwell Lewis Neal
Plos One. 2014-10-28 - 35 citationsThe Transcriptional Regulatory Network of Proneural Glioma Determines the Genetic Alterations Selected during Tumor ProgressionAdam M. Sonabend, Mukesh Bansal, Paolo Guarnieri, Liang Lei, Benjamin Amendolara
Cancer Research. 2014-03-01
Grant Support
- Leveraging doxorubicin immune-modulation, blood-brain barrier opening, and personalized medicine for effective immunotherapy in glioblastoma. A mechanistic approach and pharmacokinetic trial.NIH / NCI2021–2026
- Blood-brain barrier disruption with implantable ultrasound to enhance paclitaxel delivery: A Phase 1-2 clinical trial in recurrent glioblastomaNIH / NCI2020–2025
- MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapyNIH / NINDS2020–2025
- TOP2A effects on transcription in gliomas: implications for personalized therapyNIH Office of the Director2015–2021
Committees
- Member of study section f, Clinical Neuro-immunology and Brain Tumor Study Section, NIH 2020 - Present
Research History
- Research Fellow in Neuro-oncology at The Gabriele Bartoli Brain Tumor Laboratory, Herbert Irving Comprehensive Cancer Center, Columbia University2009 - 2013
- Research Associate at The University of Chicago Brain Tumor LaboratoryUnder the supervision of Dr Maciej S. Lesniak, I conducted conducting research on novel strategies using stem cells to deliver oncolytic adenoviruses for brain tumors.2007 - 2008
Professional Memberships
- Member
- Member
- Society of Neuro-OncologyMember
- Congress of Neurological SurgeonsMember
- Leksell Gamma Knife SocietyMember
- Center for Cancer GenomicsMember
- Lou and Jean Malnati Brain Tumor Institute/ Northwestern Brain Tumor SPORE Developmental Research and Career Enhancement Awards (2020)Grant Reviewer
- Eisenberg Foundation Research Grants/Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago IL (2020)Grant Reviewer
- Office of Research Advisory Committee, College of Physicians and Surgeons Columbia UniversityMember
- Faculty Development & Recognition Task Force, College of Physicians and Surgeons Columbia UniversityMember
- Brain Tumor Clinically Integrated Program Committee for Northwestern MedicineMember
- Robert H Lurie Comprehensive Cancer CenterGuest Speaker
Other Languages
- Spanish, Italian, Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: